Estimates of cancer incidence and mortality in Europe in 2008.

By J. Ferlay, D. Parkin, E. Steliarova-Foucher. European Journal of Cancer, 2010

2,510 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes (2012, background): “Pancreatic ductal adenocarcinoma accounts for approximately 130,000 deaths each year in Europe and the United States [27,28].”
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. (2014, background): “Approximately 15% of male cancers are PCa in developed countries, compared with 4% of male cancers in developing countries [4].”
The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. (2012, neutral): “%) in Eastern Europe and the United Kingdom.”
Cost of disorders of the brain in Europe 2010. (2011, neutral): “Compared with the data in Europe in 1995 (Bray et al., 2002) used in the EBC2005 study (Andlin-Sobocki et al.”
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release (2010, neutral): “2 million cancer cases were diagnosed (2).”
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches (2022, background): “However, the prostate-specific antigen (PSA) test remains to be the keystone for prostate cancer screening [17].”